epilepsiaEpilepsy and paroxysmal conditionsЭпилепсия и пароксизмальные состояния2077-83332311-4088IRBIS LLC10.17749/2077-8333/epi.par.con.2021.093epilepsia-734Research ArticleEVENTSСОБЫТИЯEffectiveness, safety and assessing the results of drug therapy in patients with epilepsyОб эффективности, безопасности и оценке результатов лекарственной терапии больных эпилепсиейРедакционнаястатьяEditorialArticle202129102021133306310Copyright © Editorial a., 20212021Редакционная с.Editorial a.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epilepsia.su/jour/article/view/734

On June 26, 2021, a meeting of the experts of the Russian League Against Epilepsy (RLAE) was held, dedicated to the effectiveness, safety and assessing the results of drug therapy in patients with epilepsy. Having considered the history of the issue and guided by domestic and foreign experience, the participants discussed the problems associated with the use of various antiepileptic drugs for different forms of epilepsy in patients of different sex and age. Special attention was paid to psychiatric comorbidity in patients with epilepsy, increasing their compliance with treatment and quality of life. The article presents the Resolution of RLAE experts meeting adopted as a result of the discussion.

26 июня 2021 г. состоялось заседание экспертов Российской Противоэпилептической Лиги (РПЭЛ), посвященное теме эффективности, безопасности и оценки результатов лекарственной терапии больных эпилепсией. Рассмотрев историю вопроса и руководствуясь отечественным и зарубежным опытом, участники обсудили проблемы, связанные с использованием различных противоэпилептических препаратов при разных формах эпилепсии у пациентов разного пола и возраста. Особое внимание было уделено психиатрической коморбидности у больных эпилепсией, повышению приверженности лечению и качества жизни пациентов. В статье представлена Резолюция заседания экспертов РПЭЛ, принятая в результате дискуссии.

Эпилепсияэффективность терапиибезопасность терапииоценка результатов терапиипротивоэпилептические препаратыламотриджинклинические исследованияпереносимость препаратапсихиатрическая коморбидностьприверженность лечениюкачество жизниEpilepsyeffectiveness of therapysafety of therapyassessing therapy resultsantiepileptic drugslamotrigineclinical studiesdrug tolerabilitypsychiatric comorbiditycompliance with treatmentquality of lifeПубликация подготовлена при финансовой поддержке компании «Алкалоид». Авторы несут полную ответственность за содержание публикации и редакционные решенияThis article was published with the financial support of Alkaloid company. The authors are fully responsible for the content of the article and editorial decisions.ReferencesShorvon S.D. Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909–1958. Epilepsia. 2009; 50 (Suppl. 3): 69–92. https://doi.org/10.1111/j.1528-1167.2009.02041.x.Shorvon S.D. Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909–1958. Epilepsia. 2009; 50 (Suppl. 3): 69–92. https://doi.org/10.1111/j.1528-1167.2009.02041.x.Campos M.S., Ayres L.R., Morelo M.R., et al. Efficacy and tolerability of antiepileptic drugs in patients with focal epilepsy: systematic review and network meta-analyses. Pharmacotherapy. 2016; 36 (12): 1255–71. https://doi.org/10.1002/phar.1855.Campos M.S., Ayres L.R., Morelo M.R., et al. Efficacy and tolerability of antiepileptic drugs in patients with focal epilepsy: systematic review and network meta-analyses. Pharmacotherapy. 2016; 36 (12): 1255–71. https://doi.org/10.1002/phar.1855.Campos M.S., Ayres L.R., Morelo M.R., et al. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int J Clin Pharm. 2018; 40 (3): 589–98. https://doi.org/10.1007/s11096-018-0641-9.Campos M.S., Ayres L.R., Morelo M.R., et al. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int J Clin Pharm. 2018; 40 (3): 589–98. https://doi.org/10.1007/s11096-018-0641-9.Strandberg M.C., Söderberg-Löfdal K., Kimland E., et al. Evidencebased anti-seizure monotherapy in newly diagnosed epilepsy: a new approach. Acta Neurol Scand. 2020; 142 (4): 323–32. https://doi.org/10.1111/ane.13312.Strandberg M.C., Söderberg-Löfdal K., Kimland E., et al. Evidencebased anti-seizure monotherapy in newly diagnosed epilepsy: a new approach. Acta Neurol Scand. 2020; 142 (4): 323–32. https://doi.org/10.1111/ane.13312.NICE. Epilepsies: diagnosis and management. Clinical guideline. URL: https://www.nice.org.uk/guidance/cg137 (дата обращения 15.07.2021).NICE. Epilepsies: diagnosis and management. Clinical guideline. URL: https://www.nice.org.uk/guidance/cg137 (дата обращения 15.07.2021).Marson A., Burnside G., Appleton R., et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021; 397 (10282): 1375–86. https://doi.org/10.1016/S0140-6736(21)00246-4.Marson A., Burnside G., Appleton R., et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021; 397 (10282): 1375–86. https://doi.org/10.1016/S0140-6736(21)00246-4.Kanner A.M. Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment. Epilepsy Behav. 2002; 3 (6S1): 7–13. https://doi.org/10.1016/s1525-5050(02)00536-x.Kanner A.M. Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment. Epilepsy Behav. 2002; 3 (6S1): 7–13. https://doi.org/10.1016/s1525-5050(02)00536-x.Cramer J.A., Blum D., Reed M., et al. The influence of comorbid depression on seizure severity. Epilepsia. 2003; 44 (12): 1578–84. https://doi.org/10.1111/j.0013-9580.2003.28403.x.Cramer J.A., Blum D., Reed M., et al. The influence of comorbid depression on seizure severity. Epilepsia. 2003; 44 (12): 1578–84. https://doi.org/10.1111/j.0013-9580.2003.28403.x.Tellez-Zenteno J.F., Patten S.B., Jetté N., et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007; 48 (12): 2336–44. https://doi.org/10.1111/j.1528-1167.2007.01222.x.Tellez-Zenteno J.F., Patten S.B., Jetté N., et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007; 48 (12): 2336–44. https://doi.org/10.1111/j.1528-1167.2007.01222.x.Мосолов С.Н., Костюкова Е.Г. Клинические рекомендации по фармакопрофилактике рецидивов биполярного расстройства. Часть 2. Современная терапия психических расстройств. 2008; 3: 44–57.Mosolov S.N., Kostyukova Е.G. Clinical guidelines for pharmacoprophylaxis of recurrent bipolar disorder. Part 2. Current Therapy of Mental Disorders. 2008; 3: 44–57 (in Russ.).Mula M., Kanner A.M., Jetté N., Sander J.W. Psychiatric comorbidities in people with epilepsy. Neurol Clin Pract. 2021; 11 (2): e112–20. https://doi.org/10.1212/CPJ.0000000000000874.Mula M., Kanner A.M., Jetté N., Sander J.W. Psychiatric comorbidities in people with epilepsy. Neurol Clin Pract. 2021; 11 (2): e112–20. https://doi.org/10.1212/CPJ.0000000000000874.Aaberg K.M., Bakken I.J., Lossius M.I., et al. Comorbidity and childhood epilepsy: a nationwide registry study. Pediatrics. 2016; 138 (3): e20160921. https://doi.org/10.1542/peds.2016-0921.Aaberg K.M., Bakken I.J., Lossius M.I., et al. Comorbidity and childhood epilepsy: a nationwide registry study. Pediatrics. 2016; 138 (3): e20160921. https://doi.org/10.1542/peds.2016-0921.Josephson C.B., Lowerison M., Vallerand I., et al. Association of depression and treated depression with epilepsy and seizure outcomes: a multicohort analysis. JAMA Neurol. 2017; 74 (5): 533–9. https://doi.org/10.1001/jamaneurol.2016.5042.Josephson C.B., Lowerison M., Vallerand I., et al. Association of depression and treated depression with epilepsy and seizure outcomes: a multicohort analysis. JAMA Neurol. 2017; 74 (5): 533–9. https://doi.org/10.1001/jamaneurol.2016.5042.Stephen L.J., Wishart A., Brodie M.J. Psychiatric side effects and antiepileptic drugs: observations from prospective audits. Epilepsy Behav. 2017; 71 (Pt. A): 73–8. https://doi.org/10.1016/j.yebeh.2017.04.003.Stephen L.J., Wishart A., Brodie M.J. Psychiatric side effects and antiepileptic drugs: observations from prospective audits. Epilepsy Behav. 2017; 71 (Pt. A): 73–8. https://doi.org/10.1016/j.yebeh.2017.04.003.Frye R.E., Rossignol D., Casanova M.F., et al. A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health. 2013; 1: 31. https://doi.org/10.3389/fpubh.2013.00031.Frye R.E., Rossignol D., Casanova M.F., et al. A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health. 2013; 1: 31. https://doi.org/10.3389/fpubh.2013.00031.Moavero R., Santarone M.E., Galasso C., Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev. 2017; 39 (6): 464–9. https://doi.org/10.1016/j.braindev.2017.01.006.Moavero R., Santarone M.E., Galasso C., Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev. 2017; 39 (6): 464–9. https://doi.org/10.1016/j.braindev.2017.01.006.Гусев Е.И., Бурд Г.С. Эпилепсия: ламиктал в лечении больных эпилепсией. M.: Буклет; 1994: 63 с.Gusev Е.I., Burd G.S. Epilepsy: lamictal in the treatment of patients with epilepsy. Moscow: Buklet; 1994: 63 рр. (in Russ.).Зенков Л.Р. Ламиктал в лечении эпилепсии. М.; 2006: 39 с.Zenkov L.R. Lamictal in the treatment of epilepsy. Мoscow; 2006: 39 pp.Карлов В.А. Эпилепсия у детей и взрослых женщин и мужчин. Руководство для врачей. 2-е изд. М.: БИНОМ; 2019: 896 с.Karlov V.А. Epilepsy in children and adult women and men. A guide for doctors. 2nd ed. Мoscow: BINOM; 2020: 896 pp. (in Russ.).Власов П.Н., Дранко Д.В., Агранович О.В. Ламотриджин в терапии эпилепсии у женщин. Журнал невропатологии и психиатрии им. С.С. Корсакова. 2011; 111 (5-2): 38–42.Vlasov P.N., Dranko D.V., Agranovich О.V. Lamotrigine in the treatment of epilepsy in women. S.S. Korsakov Journal of Neurology and Psychiatry. 2011; 111 (5-2): 38–42 (in Russ.).Резолюция заседания экспертов Российской Противоэпилептической Лиги по вопросам терапии женщин с эпилепсией. Эпилепсия и пароксизмальные состояния. 2019; 11 (2): 195–9.Resolution of the meeting of experts of the Russian League Against Epilepsy on the treatment of women with epilepsy. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. 2019; 11 (2): 195–9 (in Russ.).

The authors declare that there are no conflicts of interest present.